Grygorii Ursol

5.3k citations
6 papers · 268 indexed · 1 hit paper · h-index 4
Topics
Cancer Immunotherapy and Biomarkers (5 papers)Lung Cancer Treatments and Mutations (3 papers)Colorectal Cancer Treatments and Studies (2 papers)

In The Last Decade

Grygorii Ursol

6 papers receiving 266 citations

Hit Papers

Durvalumab With or Without Tremelimumab in Combination Wi...2022202620232024202250100150200

Peers

Grygorii Ursol
Comparison fields: 5 of 33
  • Oncology 233
  • Pulmonary and Respiratory Medicine 143
  • Immunology 54
  • Molecular Biology 27
  • Cancer Research 24
Replace Farah Louise Lim with:
Farah Louise Lim United Kingdom
Hai-Yan Tu China
Joanna Wójcik-Tomaszewska United States
Takehiro Tozuka Japan
Hiroshi Imazeki Japan
Firas Badin United States
Qian Miao China
Paz J. Vellanki United States
Ahmed Bilal Khalid United States
M. Dómine Gómez Spain
Grygorii Ursol relative to Farah Louise Lim United Kingdom Farah Louise Lim's profile →
Citations per field
00.5×1.5×
Farah Louise Lim · 1×
Citations per year

Countries citing papers authored by Grygorii Ursol

Since Specialization
Citations

This map shows the geographic impact of Grygorii Ursol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grygorii Ursol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grygorii Ursol more than expected).

Fields of papers citing papers by Grygorii Ursol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grygorii Ursol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grygorii Ursol. The network helps show where Grygorii Ursol may publish in the future.

Co-authorship network of co-authors of Grygorii Ursol

This figure shows the co-authorship network connecting the top 25 collaborators of Grygorii Ursol. A scholar is included among the top collaborators of Grygorii Ursol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Grygorii Ursol. Grygorii Ursol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
#WorkIndexed citations
1 2
2 4
3
Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non–Small-Cell Lung Cancer: The Phase III POSEIDON Studybreakdown →
238
4 3
5 18
6 3

About Grygorii Ursol

Grygorii Ursol is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology, having authored 6 papers that have together received 268 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Lung Cancer Treatments and Mutations (3 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Oncology (233 citations), Pulmonary and Respiratory Medicine (143 citations) and Immunology (54 citations). Grygorii Ursol has collaborated with scholars based in United Kingdom, United States and Spain. Frequent co-authors include Byoung Chul Cho, Farah Louise Lim, Melissa L. Johnson, Alexander Luft, Niels Reinmuth, Jorge Alatorre-Alexander, Xiaojin Shi, Sang‐We Kim, К. К. Лактионов and Tony Mok. Their work appears in journals such as Journal of Clinical Oncology, Lung Cancer and Clinical Lung Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026